996 participants
Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy in Routine Clinical Practice
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-07-09
- Start Date:
- 2025-05-22
- Completion:
- 2026-06-30
Conditions
- Atherosclerotic Cardiovascular Disease
Interventions
- DRUG
No Results Yet